Eli Lilly and (LLY) Revenue — Quarter Ended Sep 30, 2025
Eli Lilly reported a revenue increase for the quarter. The growth compared to the same period a year earlier was larger than the sequential increase from the preceding quarter.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Eli Lilly reported a revenue increase for the quarter. The growth compared to the same period a year earlier was larger than the sequential increase from the preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$17.6B
Revenue reported for this quarter.
Quarter-over-quarter
+13.1%
Change from the immediately preceding quarter.
Year-over-year
+53.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$59.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $13.5B | +44.7% |
| Mar 31, 2025 | $12.7B | +45.2% |
| Jun 30, 2025 | $15.6B | +37.6% |
| Sep 30, 2025 | $17.6B | +53.9% |
Revenue performance
Revenue for the quarter rose compared to both the immediately preceding quarter and the same period a year earlier.
Quarterly comparison
The year-over-year revenue gain was stronger than the quarter-over-quarter increase, reflecting an acceleration from the prior year's level.
What to watch
Monitor whether the growth trajectory can be sustained in upcoming periods.